Vaccine and treatment evaluation units (vteu) protocol development and implementation task area b-c phase 1 anthrax vaccine trial for task order 17-0093.B1C1.0119
Ended Awarded Last action
- Contract number
- 75N93019F00132
- Awardee
-
University Of Maryland, Baltimore UEI Z9CRZKD42ZT1 Part of University System Of Maryland
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,120,255
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2012144 Solicitation number
- Vaccine and treatment evaluation units (vteu) Award Notice · Posted Mar 29, 2012
- Contract value 100% obligated
- $1,120,254.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 8 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Baltimore, MD 21201, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | -$15,186 | |
| Funding Only Action | $23,948 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $952,381 | |
| Other Administrative Action | $0 | |
| Original award | $159,112 |
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $1,120,254.91 delivery order to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Vehicle (IDV). The order is for the development and implementation of a Phase 1 clinical trial evaluating an anthrax vaccine, which falls under Task Order 17-0093.B1C1.0119 of the VTEU program. This award does not have a set-aside designation. UMB, a major public research university, will conduct the protocol development and implementation of the anthrax vaccine trial as the prime contractor. The VTEU program is a key initiative of NIAID, a component of the National Institutes of Health (NIH), to support research and clinical evaluation of vaccines and treatments for infectious diseases.
Quick answers
Who was awarded contract 75N93019F00132?
75N93019F00132 was awarded to University Of Maryland, Baltimore by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 5, 2019.
How much is contract 75N93019F00132 worth?
The government has obligated $1,120,255 on 75N93019F00132.
Is contract 75N93019F00132 an order under another contract?
Yes. 75N93019F00132 is a delivery order under HHSN272201300022I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).
Was contract 75N93019F00132 competed?
The extent of competition for 75N93019F00132 was full and open competition. The government received 8 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award